[
  {
    "ts": "2025-12-18T21:05:00+00:00",
    "headline": "Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resm",
    "url": "https://finance.yahoo.com/news/resmed-announces-participation-44th-annual-210500088.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "57610628-963c-3a2d-a00f-d0db2a4656ea",
      "content": {
        "id": "57610628-963c-3a2d-a00f-d0db2a4656ea",
        "contentType": "STORY",
        "title": "Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resm",
        "pubDate": "2025-12-18T21:05:00Z",
        "displayTime": "2025-12-18T21:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/dea44210d8c42564e1f27e13fba486ae",
          "originalWidth": 1182,
          "originalHeight": 247,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3W0YPXC5YT.K3LOSdX34Sw--~B/aD0yNDc7dz0xMTgyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/dea44210d8c42564e1f27e13fba486ae.cf.webp",
              "width": 1182,
              "height": 247,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FSnpDKdN2e2mL..bKPxyOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/dea44210d8c42564e1f27e13fba486ae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/resmed-announces-participation-44th-annual-210500088.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/resmed-announces-participation-44th-annual-210500088.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-18T01:12:59+00:00",
    "headline": "ResMed (RMD): Revisiting Valuation After Recent Share Price Pullback",
    "summary": "ResMed (RMD) has quietly drifted lower over the past week, but the stock is still up this year, which raises a straightforward question for investors: is this dip an opportunity or a warning? See our latest analysis for ResMed. That recent pullback, including a 7 day share price return of minus 2.21 percent and a 90 day share price return of minus 10.01 percent, looks more like cooling momentum than a broken story. This is particularly the case with the year to date share price still higher...",
    "url": "https://finance.yahoo.com/news/resmed-rmd-revisiting-valuation-recent-011259742.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "8fb62778-87a9-3dbc-9397-862d701ffad2",
      "content": {
        "id": "8fb62778-87a9-3dbc-9397-862d701ffad2",
        "contentType": "STORY",
        "title": "ResMed (RMD): Revisiting Valuation After Recent Share Price Pullback",
        "description": "",
        "summary": "ResMed (RMD) has quietly drifted lower over the past week, but the stock is still up this year, which raises a straightforward question for investors: is this dip an opportunity or a warning? See our latest analysis for ResMed. That recent pullback, including a 7 day share price return of minus 2.21 percent and a 90 day share price return of minus 10.01 percent, looks more like cooling momentum than a broken story. This is particularly the case with the year to date share price still higher...",
        "pubDate": "2025-12-18T01:12:59Z",
        "displayTime": "2025-12-18T01:12:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/resmed-rmd-revisiting-valuation-recent-011259742.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/resmed-rmd-revisiting-valuation-recent-011259742.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]